JPMorgan Chase & Co Raises Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target to $88 00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Ultragenyx Pharmaceutical s (RARE) Overweight Rating Reaffirmed at Cantor Fitzgerald themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com upgraded shares of Ultragenyx Pharmaceutical (NASDAQ:RARE – Free Report) from a sell rating to a hold rating in a research report released on Friday. Other research analysts also recently issued research reports about the stock. Morgan Stanley decreased their target price on shares of Ultragenyx Pharmaceutical from $90.00 to $84.00 and set an overweight […]
Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) Receives Average Rating of Buy from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com cut shares of Ultragenyx Pharmaceutical (NASDAQ:RARE – Free Report) from a hold rating to a sell rating in a research note released on Wednesday. Other research analysts have also issued research reports about the company. Cantor Fitzgerald reissued an overweight rating and issued a $114.00 target price on shares of Ultragenyx Pharmaceutical in a […]